2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation

被引：63

作者：

Chao, Tze-Fan ^{[1
,2
,3
]}

Joung, Boyoung ^{[4
]}

Takahashi, Yoshihide ^{[5
]}

Lim, Toon Wei ^{[6
]}

Choi, Eue-Keun ^{[7
]}

Chan, Yi-Hsin ^{[8
,9
]}

Guo, Yutao ^{[10
]}

Sriratanasathavorn, Charn ^{[11
]}

Oh, Seil ^{[7
]}

Okumura, Ken ^{[12
]}

Lip, Gregory Y. H. ^{[13
,14
,15
]}

机构：

[1] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, 201,Sec 2,Shih Pai Rd, Taipei, Taiwan

[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan

[3] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan

[4] Yonsei Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea

[5] Tokyo Med & Dent Univ, Dept Adv Arrhythmia Res, Tokyo, Japan

[6] Natl Univ Singapore Hosp, Natl Univ Heart Ctr, Singapore, Singapore

[7] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[8] Chang Gung Mem Hosp, Microscopy Core Lab, Taoyuan, Taiwan

[9] Chang Gung Univ, Coll Med, Taoyuan, Taiwan

[10] Chinese Peoples Liberat Army Gen Hosp, Pulm Vessel & Thrombot Dis, Beijing, Peoples R China

[11] Her Majesty Cardiac Ctr, Siriraj, Thailand

[12] Saiseikai Kumamoto Hosp, Div Cardiol, Kumamoto, Japan

[13] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England

[14] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England

[15] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark

来源：

JOURNAL OF ARRHYTHMIA | 2021年 / 37卷 / 06期

关键词：

APHRS; atrial fibrillation; consensus guidelines; stroke prevention; ANTAGONIST ORAL ANTICOAGULANTS; TRANSIENT ISCHEMIC ATTACK; CARDIAC-ARRHYTHMIA SOCIETY; MOBILE HEALTH TECHNOLOGY; BLEEDING RISK-ASSESSMENT; CARDIOLOGY WORKING GROUP; VITAMIN-K ANTAGONISTS; SOUTHERN AFRICA CASSA; AF-TIMI; 48; APPENDAGE CLOSURE;

D O I：

10.1002/joa3.12652

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The Practice Guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summarized them in this 2021 focused update of the 2017 consensus guidelines of the APHRS on stroke prevention in AF. We highlighted and focused on several issues, including the importance of AF Better Care (ABC) pathway, the advantages of non-vitamin K antagonist oral anticoagulants (NOACs) for Asians, the considerations of use of NOACs for Asian patients with AF with single 1 stroke risk factor beyond gender, the role of lifestyle factors on stroke risk, the use of oral anticoagulants during the "coronavirus disease 2019" (COVID-19) pandemic, etc. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician's decision remains the most important factor in the management of AF.

引用

页码：1389 / 1426

页数：38

共 318 条

[1] Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis [J].

Abdulla, Jawdat ;

Nielsen, Jens Rokkedal .

EUROPACE, 2009, 11 (09) :1156-1159

[2] Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation A Randomized Clinical Trial [J].

Abed, Hany S. ;

Wittert, Gary A. ;

Leong, Darryl P. ;

Shirazi, Masoumeh G. ;

Bahrami, Bobak ;

Middeldorp, Melissa E. ;

Lorimer, Michelle F. ;

Lau, Dennis H. ;

Antic, Nicholas A. ;

Brooks, Anthony G. ;

Abhayaratna, Walter P. ;

Kalman, Jonathan M. ;

Sanders, Prashanthan .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (19) :2050-2060

[3] Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study [J].

Ahn, Hyo-Jeong ;

Lee, So-Ryoung ;

Choi, Eue-Keun ;

Han, Kyung-Do ;

Jung, Jin-Hyung ;

Lim, Jae-Hyun ;

Yun, Jun-Pil ;

Kwon, Soonil ;

Oh, Seil ;

Lip, Gregory Y. H. .

PLOS MEDICINE, 2021, 18 (06)

[4] Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis [J].

Ando, Giuseppe ;

Capranzano, Piera .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 231 :162-169

[5] Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention A North American Perspective-2016 Update [J].

Angiolillo, Dominick J. ;

Goodman, Shaun G. ;

Bhatt, Deepak L. ;

Eikelboom, John W. ;

Price, Matthew J. ;

Moliterno, David J. ;

Cannon, Christopher P. ;

Tanguay, Jean-Francois ;

Granger, Christopher B. ;

Mauri, Laura ;

Holmes, David R. ;

Gibson, C. Michael ;

Faxon, David P. .

CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (11)

[6] Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism - First Results From the SALUTE Trial - [J].

Aonuma, Kazutaka ;

Yamasaki, Hiro ;

Nakamura, Masato ;

Ootomo, Tatsushi ;

Takayama, Morimasa ;

Ando, Kenji ;

Hirao, Kenzo ;

Morino, Yoshihiro ;

Hayashida, Kentaro ;

Kusano, Kengo ;

Main, Michael L. ;

Saito, Shigeru .

CIRCULATION JOURNAL, 2018, 82 (12) :2946-+

[7] Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT2R2 Score [J].

Apostolakis, Stavros ;

Sullivan, Renee M. ;

Olshansky, Brian ;

Lip, Gregory Y. H. .

CHEST, 2013, 144 (05) :1555-1563

[8] The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal [J].

Asuncion Esteve-Pastor, Maria ;

Roldan, Vanessa ;

Miguel Rivera-Caravaca, Jose ;

Ramirez-Macias, Inmaculada ;

Lip, Gregory Y. H. ;

Marin, Francisco .

THROMBOSIS AND HAEMOSTASIS, 2019, 119 (12) :1901-1919

[9] Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [J].

Avezum, Alvaro ;

Lopes, Renato D. ;

Schulte, Phillip J. ;

Lanas, Fernando ;

Gersh, Bernard J. ;

Hanna, Michael ;

Pais, Prem ;

Erol, Cetin ;

Diaz, Rafael ;

Cecilia Bahit, M. ;

Bartunek, Jozef ;

De Caterina, Raffaele ;

Goto, Shinya ;

Ruzyllo, Witold ;

Zhu, Jun ;

Granger, Christopher B. ;

Alexander, John H. .

CIRCULATION, 2015, 132 (08) :624-632

[10] Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States Influence of Hospital Volume [J].

Badheka, Apurva O. ;

Chothani, Ankit ;

Mehta, Kathan ;

Patel, Nileshkumar J. ;

Deshmukh, Abhishek ;

Hoosien, Michael ;

Shah, Neeraj ;

Singh, Vikas ;

Grover, Peeyush ;

Savani, Ghanshyambhai T. ;

Panaich, Sidakpal S. ;

Rathod, Ankit ;

Patel, Nilay ;

Arora, Shilpkumar ;

Bhalara, Vipulkumar ;

Coffey, James O. ;

O'Neill, William ;

Makkar, Raj ;

Grines, Cindy L. ;

Schreiber, Theodore ;

Di Biase, Luigi ;

Natale, Andrea ;

Viles-Gonzalez, Juan F. .

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2015, 8 (01) :42-48

← 1 2 3 4 5 6 7 8 9 10 →